Krzysztof Jóźwiak

Affiliations: 
Department of Biopharmacy Medical University of Lublin 
Google:
"Krzysztof Jóźwiak"
Mean distance: (not calculated yet)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Plazinski W, Archala A, Jozwiak K, et al. (2024) Unraveling the Structural Basis of Biased Agonism in the β-Adrenergic Receptor Through Molecular Dynamics Simulations. Proteins
Malek R, Sałat K, Totoson P, et al. (2024) Discovery of New Highly Potent Histamine H Receptor Antagonists, Calcium Channel Blockers, and Acetylcholinesterase Inhibitors. Acs Chemical Neuroscience
Pachón-Angona I, Bernard PJ, Simakov A, et al. (2024) Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties. Pharmaceutics. 16
Zaręba P, Łątka K, Mazur G, et al. (2023) Discovery of novel multifunctional ligands targeting GABA transporters, butyrylcholinesterase, β-secretase, and amyloid β aggregation as potential treatment of Alzheimer's disease. European Journal of Medicinal Chemistry. 261: 115832
Dakhlaoui I, Bernard PJ, Pietrzak D, et al. (2023) Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease Treatment. International Journal of Molecular Sciences. 24
Maciag M, Plazinski W, Pulawski W, et al. (2023) A comprehensive pharmacological analysis of fenoterol and its derivatives to unravel the role of β-adrenergic receptor in zebrafish. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 160: 114355
Malek R, Simakov A, Davis A, et al. (2022) Biginelli Reaction Synthesis of Novel Multitarget-Directed Ligands with Ca Channel Blocking Ability, Cholinesterase Inhibition, Antioxidant Capacity, and Nrf2 Activation. Molecules (Basel, Switzerland). 28
Wnorowski A, Dudzik D, Bernier M, et al. (2022) Deprogramming metabolism in pancreatic cancer with a bi-functional GPR55 inhibitor and biased β adrenergic agonist. Scientific Reports. 12: 3618
Pachón-Angona I, Maj M, Wnorowski A, et al. (2021) Synthesis of new Hantzsch adducts showing Ca channel blockade capacity, cholinesterase inhibition and antioxidant power. Future Medicinal Chemistry
Targowska-Duda KM, Budzynska B, Michalak A, et al. (2021) Type I and type II positive allosteric modulators of α7 nicotinic acetylcholine receptors induce antidepressant-like activity in mice by a mechanism involving receptor potentiation but not neurotransmitter reuptake inhibition. Correlation with mTOR intracellular pathway activation. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 52: 31-47
See more...